COQ6 Protein

📖 Wiki Page

protein920 wordssynced 2026-04-02

COQ6 Protein

Introduction

Coq6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

COQ6 Protein (Coenzyme Q Biosynthesis Factor COQ6) is a mitochondrial flavin-dependent monooxygenase that catalyzes hydroxylation reactions in coenzyme Q (CoQ) biosynthesis. COQ6 is essential for the conversion of demethoxy-ubiquinone (DMQ) to ubiquinone (CoQ10), a critical step in the mitochondrial electron transport chain. [@gianazza2016]

Protein Information

<div class="infobox infobox-protein"> [@desbats2015]
<table> [@stefely2016]
<tr><th>Protein Name</th><td>COQ6</td></tr> [@hargreaves2014]
<tr><th>Gene</th><td>[COQ6](/proteins/coq6-protein)</td></tr> [@chocron2022]
<tr><th>UniProt ID</th><td>Q9Y2Z4</td></tr> [@liu2020]
<tr><th>Molecular Weight</th><td>~51 kDa</td></tr> [@wang2021]
<tr><th>Subcellular Localization</th><td>Inner mitochondrial membrane</td></tr>
<tr><th>Cofactors</th><td>FAD, NADPH</td></tr>
<tr><th>Protein Family</th><td>Flavin-dependent monooxygenases</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Structure

COQ6 contains several distinct domains:

...

COQ6 Protein

Introduction

Coq6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Protein Information

Structure

COQ6 contains several distinct domains:

N-terminal mitochondrial targeting sequence - Directs protein to mitochondria

FAD-binding domain - Flavin adenine dinucleotide cofactor for oxidation reactions

NADPH-binding domain - Provides reducing equivalents for monooxygenase activity

Catalytic monooxygenase domain - Contains the active site for DMQ hydroxylation

The crystal structure reveals a Rossmann-like fold for cofactor binding, with a distinctive substrate-binding pocket that recognizes the hydrophobic CoQ intermediates.

Normal Function

CoQ Biosynthesis

COQ6 catalyzes the C5-hydroxylation of demethoxy-ubiquinone (DMQ) to form ubiquinone (CoQ10). This reaction is essential because:

CoQ10 is a vital electron carrier in the mitochondrial respiratory chain
It transfers electrons from Complex I and II to Complex III
It also functions as an antioxidant in mitochondrial membranes

Mitochondrial Support

Electron Transport - Enables proper Complex I and II function

Oxidative Phosphorylation - Supports ATP production

Membrane Potential - Maintains mitochondrial membrane potential

[ROS](/entities/reactive-oxygen-species) Regulation - Reduces electron leak and superoxide production

Brain Region Distribution

COQ6 is expressed in multiple brain regions:

Cerebral [Cortex](/brain-regions/cortex) - Moderate expression in pyramidal [neurons](/entities/neurons)
Cerebellum - High expression in Purkinje cells
[Hippocampus](/brain-regions/hippocampus) - Expression in CA1-CA3 pyramidal neurons
Basal Ganglia - Present in striatal medium spiny neurons
Brainstem - Detected in dopaminergic neurons of the substantia nigra

Molecular Mechanisms

Catalytic Cycle

FAD binds to COQ6 and is reduced by NADPH

Reduced FAD transfers electrons to molecular oxygen, forming FAD-OOH

The peroxy intermediate hydroxylates DMQ at the C5 position

Water is released and CoQ10 is produced

Protein Interactions

COQ6 interacts with other CoQ biosynthesis proteins:

COQ5 - Works upstream in the pathway
COQ7 - Cooperates in CoQ ring modification
COQ4 - Scaffold protein for complex assembly
COQ9 - Stabilizes the CoQ biosynthesis complex

Role in Disease

Primary CoQ10 Deficiency

COQ6 mutations cause primary CoQ10 deficiency, characterized by:

Steroid-resistant nephrotic syndrome - Kidney disease with proteinuria
Sensorineural hearing loss - Progressive hearing impairment
Ataxia - Cerebellar ataxia with coordination difficulties
Encephalomyopathy - Neuromuscular disease with weakness
Developmental delay - Neurodevelopmental abnormalities

Neurodegenerative Disease Connections

While COQ6 mutations cause rare Mendelian disorders, CoQ10 deficiency is increasingly recognized in:

Parkinson's Disease

Complex I deficiency in PD substantia nigra
CoQ10 levels reduced in PD patient mitochondria
CoQ10 supplementation trials in PD (failed phase III)
COQ6 variants may modify PD risk

Alzheimer's Disease

Mitochondrial dysfunction in AD brain
CoQ10 levels decline with age and AD
Antioxidant properties relevant to [Aβ](/proteins/amyloid-beta) toxicity

Amyotrophic Lateral Sclerosis

Mitochondrial dysfunction in ALS motor neurons
Energy metabolism deficits
CoQ10 has been tested in ALS clinical trials

Multiple System Atrophy

CoQ10 deficiency reported in MSA patients
Mitochondrial Complex I defects
Candidate for CoQ10 therapy

Therapeutic Targeting

Current Approaches

| Treatment | Mechanism | Status |
|-----------|-----------|--------|
| Ubiquinol (CoQ10) | Electron carrier, antioxidant | Supplements available |
| Idebenone | Synthetic CoQ10 analog | Approved for Friedreich's ataxia |
| MitoQ | Mitochondria-targeted CoQ10 | Research phase |
| CoQ10 analogs | Enhanced bioavailability | Clinical trials |

Challenges

Bioavailability - CoQ10 has poor oral absorption

Mitochondrial delivery - Getting compounds into mitochondria

[Blood-brain barrier](/entities/blood-brain-barrier) - Limited CNS penetration

Dosage - Optimal dosing unclear

Research Directions

Mitochondria-targeted CoQ10 derivatives (MitoQ, SkQ1)
Gene therapy approaches to increase CoQ biosynthesis
Combination therapies addressing multiple mitochondrial defects
Biomarkers for CoQ10 deficiency diagnosis
Personalized medicine based on genotype

Animal Models

Coq6 knockout mice - Embryonic lethal, severe mitochondrial defects
Zebrafish coq6 models - Show renal and neurological phenotypes
Drosophila coq6 - Useful for studying CoQ biosynthesis

External Links

[UniProt: Q9Y2Z4](https://www.uniprot.org/uniprot/Q9Y2Z4)
[GeneCards: COQ6](https://www.genecards.org/cgi-bin/carddisp.pl?gene=COQ6)
[OMIM: 614647](https://omim.org/entry/614647)

Background

The study of Coq6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Heeringa SF, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21727188/)

[Gianazza E, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/26663225/)

[Desbats MA, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25999232/)

[Stefely JA, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27466201/)

[Unknown, Hargreaves IP (2014). Coenzyme Q10 as a therapy for mitochondrial disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24815075/)

[Chocron ES, et al, (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/36434291/)

[Liu J, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32945123/)

[Wang Y, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33668573/)

📖 View canonical wiki page →

COQ6 Protein

COQ6 Protein

Introduction

Overview

Protein Information

Structure

COQ6 Protein

Introduction

Overview

Protein Information

Structure

Normal Function

CoQ Biosynthesis

Mitochondrial Support

Brain Region Distribution

Molecular Mechanisms

Catalytic Cycle

Protein Interactions

Role in Disease

Primary CoQ10 Deficiency

Neurodegenerative Disease Connections

Parkinson's Disease

Alzheimer's Disease

Amyotrophic Lateral Sclerosis

Multiple System Atrophy

Therapeutic Targeting

Current Approaches

Challenges

Research Directions

Animal Models

See Also

External Links

Background

References